Jóźwiak et al. suggest that their study, “…provides evidence that preventive antiepileptic treatment in infants with tuberous sclerosis complex improves long-term epilepsy control and cognitive outcome at school age.” The study is problematic, however, because it compares two groups that have been ascertained in entirely different ways: the “Standard” group after presentation with tuberous sclerosis complex and usually epilepsy and the “Preventive” group with suspected or proven tuberous sclerosis complex but without epilepsy.
|Number of pages||2|
|Early online date||5 Apr 2020|
|Publication status||Published - 1 Sep 2020|
Bibliographical noteAcceptance date is provisional and based on date of publication.
- tuberous sclerosis complex
- antiepileptic drug treatment